TRSSF - TerrAscend Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
1.8900
+0.0100 (+0.53%)
As of 10:08AM EST. Market open.
Stock chart is not supported by your current browser
Previous Close1.8800
Open2.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range1.8857 - 2.0600
52 Week Range1.7800 - 7.0100
Volume31,236
Avg. Volume73,833
Market Cap101M
Beta (3Y Monthly)0.28
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Cannabis stocks slammed as analysts say Canopy’s new CEO faces big challenges
    MarketWatch

    Cannabis stocks slammed as analysts say Canopy’s new CEO faces big challenges

    Cannabis stocks fell Tuesday, as analysts weighing in on Canopy Growth’s new chief executive took a cautious stance, highlighting the continuing challenges facing the company.

  • Barrons.com

    British Retailer Ted Baker Is Falling as Black Friday Made Things Even Worse

    Shares in Ted Baker plummeted on Tuesday as the embattled British retailer issued another profit warning after a weaker-than-expected Black Friday.

  • Ted Baker shares tumble after disclosing overvalued inventory
    MarketWatch

    Ted Baker shares tumble after disclosing overvalued inventory

    Shares in Ted Baker took another beating on Monday after the beleaguered British retailer disclosed that its inventory had been overvalued

  • PR Newswire

    Chairman Jason Wild Acquires Shares of TerrAscend

    On November 27, 2019 Jason Wild, Chairman of TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend") acquired for his own account 50,000 shares of TerrAscend at a price of Cdn$3.42 per share. Mr. Wild is the principal of JW Asset Management Inc. which advises JW Funds, (consisting of JW Partners, LP, JW Opportunities Master Fund, Ltd., and Pharmaceutical Opportunities Fund, LP 2018). Mr. Wild purchased the shares for investment purposes.

  • Benzinga

    TerrAscend Trades Down After Announcing Q3 Results

    Terrascend Corp (OTC: TRSSF ), a global cannabis company licensed for sales in Canada, the U.S. and the European Union, released its third-quarter financial report Wednesday.  Q3 Highlights  Revenue increased from ...

  • Benzinga

    4 Observations From The First Ever 'Cannabis Investor Day'

    The uncertain regulatory environment in the U.S. has not stopped the cannabis industry from putting down roots in the secondary market. Today, more than 200 cannabis-related companies trade on OTC Markets—an alternative trading system that offers more efficient access to public markets for early stage companies—enabling companies to grow their shareholder base while creating liquidity for investors. According to Jason Paltrowitz, executive vice president, corporate services at OTC Markets, this trend is the direct result of legacy financial systems (such as exchanges) not always being receptive to emerging industries like cannabis.

  • Benzinga

    TerrAscend Enters Strategic Partnership with Cannabis Brokerage Kindred Partners

    TerrAscend Corp. (CSE: TER) (OTC: TRSSF ) said Wednesday it has entered into a strategic collaboration with Kindred Partners Inc., a cannabis brokerage and services company. Kindred will provide brokerage ...

  • Benzinga

    TerrAscend Obtains Health Canada License To Sell Cannabis Extracts, Edibles, Topicals

    Canadian cannabis company TerrAscend Corp. (CSE: TER) (OTC: TRSSF) announced Tuesday it has obtained an amendment to its existing Health Canada license that enables it to sell cannabis extracts, topicals and edibles. The news comes as the country kicks off “Cannabis 2.0,” legalizing edibles, beverages and other cannabis derivative products. The company submitted 15 SKUs to Health Canada for launch approval, including vape pens, edibles and cartridges.

  • Benzinga

    Education Remains The Biggest Challenge For Canadian Cannabis Businesses

    The one-year anniversary of legal Canadian cannabis is just around the corner, and the country plans to celebrate in a big way. Legislators introduced prohibition policies in 1923, well ahead of the U.S.

  • Benzinga

    Zelda, Ilera Therapeutics Propose Merger To Form 'One of the World's Leading Medicinal Cannabis Companies'

    Zelda Therapeutics Limited (OTC: ZLDAF), an Australian biopharmaceutical company focused on cannabinoid formulations, announced Wednesday a merger of equals with Ilera Therapeutics LLC, a private cannabis science company. With approval from Zelda’s shareholders, Zelda would acquire 100% of Ilera Therapeutics via an all-scrip — all-stock — transaction, the company said.

  • Benzinga

    TerrAscend Receives Health Canada Approval To Triple Licensed Cultivation, Processing Capacity

    TerrAscend Corp. (CSE: TER) (OTC: TRSSF ) announced Monday  that it has obtained Health Canada approval for expansion of its Mississauga, Ontario facility.  The company plans to enlarge its facility from ...

  • Benzinga

    TerrAscend Plans To Complete $25M Private Placement, Completes First Tranche With $10M From Canopy Rivers

    TerrAscend Corp. (CSE: TER) (OTC: TRSSF ) said Wednesday it plans to conclude non-brokered private placement offerings to raise $25 million by issuing units of both TerrAscend and TerrAscend Canada Inc. ...

  • Benzinga

    MediPharm Labs, TerrAscend Sign Multi-Year Supply Agreement

    MediPharm Labs Corp. (TSX: LABS)(OTC: MEDIF) said Wednesday it has signed a supply agreement with TerrAscend Canada Inc, a subsidiary of TerrAscend Corp. (CSE: TER)(OTC: TRSSF). Per the multi-year deal, MediPharm Labs will provide TerrAscend with a minimum $27 million of high-quality private label cannabis distillate in the next two years beginning this month. TerrAscend will utilize the supply to boost its production and to bring its branded products to Canada this fall, the company said.

  • Benzinga

    Syqe Partners, TerrAscend Partner To Introduce Cannabis Inhaler To Canada

    The company said its inhaler is the first metered-dose medical cannabis inhaler in the world that offers accurate, predictable and regular treatment that meets pharmaceutical standards. Syqe Medical launched the inhaler in June in the Israeli market and will now bring it to Canada via its collaboration with TerrAscend.

  • Benzinga

    TerrAscend To Fully Acquire State Flower Brand

    TerrAscend Corp. (CSE: TER) (OTC: TRSSF) announced Wednesday the signing of definitive agreements for a series of transactions to purchase ABI SF, LLC, which runs a Bay Area cannabis cultivation facility and owns the State Flower brand. At first, TerrAscend agreed to acquire 49.9% of the equity of State Flower for a total of $2.85 million from the conversion of already issued convertible debenture and subject to regulatory approvals, the company said in a press release. Now, it has agreed to purchase the remaining 50.1% of the equity of State Flower for total consideration based on future revenue in a predetermined period of 12 months.

  • Benzinga

    TerrAscend Gets CA$31.5M Investment Via Early Warrant Exercise

    Terrascend Corp  (CSE:TER)(OTC: TRSSF ) said that JW Asset Management exercised early its warrants to acquire voting shares of the company. In total, JW Asset Management exercised warrants to acquire around ...

  • Benzinga

    TerrAscend Reports Q2 Revenue Growth, Raises Guidance

    TerrAscend Corp. (CSE: TER) (OTC: TRSSF ) reported second-quarter revenue of CA $17.6 million, up 21% from CA $14.6 million in the first quarter. Its non-GAAP adjusted EBITDA was (CA $12.5 million) for ...

  • Benzinga

    The Week Ahead In Cannabis: Lottery In Ontario, Corporate Updates And Earnings

    The next five days will still be full of news surrounding the cannabis space. We have compiled a list of main things that cannabis investors should be keeping an eye on this week. Ontario Lottery And New ...

  • Benzinga

    TerrAscend Acquires Ilera In Deal Valued Upwards Of $125M

    Canada-based TerrAscend Corp (OTC:TRSSF) (CSE:TER), the first licensed for sales in Canada, the U.S. and the E.U., announced this week it's acquiring Ilera Healthcare, one of the five vertically-integrated cannabis cultivators, processors and dispensary operators in Pennsylvania. Subject to regulatory approval, the company will buy Ilera for total consideration of $125 million to $225 million, which will be paid in a combination of cash and TerrAscend shares. TerrAscend is a portfolio company of Canopy Rivers Inc (OTC: CNPOF), the investment arm of Canopy Growth Corp (NYSE: CGC).

  • Benzinga

    TerrAscend Closes Non-Brokered Private Placement Of $93M

    Cannabis cultivator TerrAscend Corp. (CSE:TER)(OTC: TRSSF )  reported the completion of its previously announced non-brokered private placement. Orders totaled an approximate CA$69 million (about $93 million ...

  • Benzinga

    TerrAscend's Revenue More Than Doubles Quarter-Over-Quarter

    Terrascend Corp (OTC: TRSSF ) reported first-quarter revenue of CA$14.6 million ($10.8 million) Thursday and reiterated its full-year guidance.  What Happened The cannabis company said its revenue surged ...

  • New Jersey Delays Recreational Pot Vote: Which Marijuana Stocks Are Most Affected?
    Motley Fool

    New Jersey Delays Recreational Pot Vote: Which Marijuana Stocks Are Most Affected?

    It's a no-go for recreational marijuana in the Garden State for now. And several marijuana stocks are feeling the sting of the state's delay.

  • New Jersey Is On the Verge of Making Recreational Marijuana Legal
    Motley Fool

    New Jersey Is On the Verge of Making Recreational Marijuana Legal

    Perhaps it's only fitting that the Garden State appears ready to "go green."

  • Benzinga

    Canada-Based TerrAscend Expands Into US Through Apothecarium Acquisition

    In addition to gaining access to retail dispensary brand "The Apothecarium" and four dispensaries in California and Nevada, TerrAscend will also have a vertically integrated operation in Nevada that includes cultivation and edible manufacturing facilities. TerrAscend is a biopharmaceutical and wellness company that operates a number of synergistic businesses.

  • 4 Under-the-Radar Marijuana Stocks That Benefit if New Jersey Legalizes Recreational Pot
    Motley Fool

    4 Under-the-Radar Marijuana Stocks That Benefit if New Jersey Legalizes Recreational Pot

    New Jersey's cannabis market could be worth $850 million by 2022.